1993
DOI: 10.1046/j.1468-2982.1993.1306413.x
|View full text |Cite
|
Sign up to set email alerts
|

Beta-Endorphin Levels are Reduced in Peripheral Blood Mononuclear Cells of Cluster Headache Patients

Abstract: Opioid system hypofunction has been postulated in cluster headache (CH) on the basis of reduced opioid levels found in the cerebrospinal fluid (CSF). In this study beta-endorphin levels were monitored in the peripheral blood mononuclear cells of 65 episodic CH patients (32 in remission and 33 in cluster period) and 50 healthy controls. Beta-endorphin levels were significantly lower than controls in CH patients experiencing both phases of the illness (ANOVA, p < 0.0001). The persistence of this abnormality duri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
8
0

Year Published

1994
1994
2014
2014

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(9 citation statements)
references
References 22 publications
1
8
0
Order By: Relevance
“…This view is supported by previous observations of altered ß-endorphin secretion [3], reduced circulating levels of opioidergic peptides [4,5] and changes of the opioidergic receptor availability in the pineal gland in CH patients [6].…”
Section: Till Sprenger Christian L Seifert Matthias Miederer Michaelsupporting
confidence: 80%
“…This view is supported by previous observations of altered ß-endorphin secretion [3], reduced circulating levels of opioidergic peptides [4,5] and changes of the opioidergic receptor availability in the pineal gland in CH patients [6].…”
Section: Till Sprenger Christian L Seifert Matthias Miederer Michaelsupporting
confidence: 80%
“…This emphasizes that gene expression studies in CH preferably would be performed on hypothalamic tissue. However, several other changes have been monitored in peripheral blood during different phases of the CH disease, especially for studies of immunological mechanisms 18–23,46 . Furthermore, the relevance of inflammatory mechanisms in CH pathophysiology has been debated 47–49 …”
mentioning
confidence: 99%
“…The release of ß-endorphin can be stimulated by interleukin 1, ACTH, ß-adrenergic activation, and polyclonal mitogens such as phytohemagglutinin A [24][25][26]. Previous reports described changes of ß-endorphin levels in circulating leukocytes in different diseases: increased levels of immunoreactive ß-endorphin have been found in peripheral blood mononuclear cells from HIV-positive subjects and patients suffering from hereditary angioneurotic edema [27,28]; decreased levels were measured in subjects suffering from cluster headache, Crohn's disease, and rheumatic diseases [29][30][31]. Normal values of immunoreactive ß-endorphin range from 20 to 40 pg/10 6 cells [27][28][29][30][31].…”
Section: Resultsmentioning
confidence: 99%